Patent details
EP3322731 Title: METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR; ANTIBODY THAT BINDS TO PROGRAMMED DEATH-1 RECEPTOR (PD-1) OR PROGRAMMED DEATH LIGAND 1 (PD-L1)
Basic Information
- Publication number:
- EP3322731
- PCT Application Number:
- US2016042297
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP167446269
- PCT Publication Number:
- WO2017011666
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR; ANTIBODY THAT BINDS TO PROGRAMMED DEATH-1 RECEPTOR (PD-1) OR PROGRAMMED DEATH LIGAND 1 (PD-L1)
- French Title of Invention:
- MÉTHODE DE TRAITEMENT DU CANCER À L'AIDE DE CONTRÔLE IMMUNITAIRE ; ANTICORPS QUI SE LIE À UNE MORT PROGRAMMÉE-1 RECEPTOR (PD-1) OU MORT PROGRAMMÉE LIGAND 1 (PD-L1)
- German Title of Invention:
- VERFAHREN ZUR BEHANDLUNG VON KREBS MIT IMMUNE CHECKPOINT-HEMMER; ANTIKÖRPER, BINDET AN PROGRAMMIERTER ZELLTOD-1-REZEPTOR (PD-1) ODER PROGRAMMIERTE TOD LIGAND 1 (PD-L1)
- SPC Number:
Dates
- Filing date:
- 14/07/2016
- Grant date:
- 13/01/2021
- EP Publication Date:
- 23/05/2018
- PCT Publication Date:
- 19/01/2017
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 13/01/2021
- EP B1 Publication Date:
- 13/01/2021
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 14/07/2036
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 06/01/2021
- Name:
- Bristol-Myers Squibb Company
- Address:
- Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)
Agent
- Name:
- MARKS & CLERK LLP
- From:
- 27/01/2021
- Address:
- BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
- To:
Inventor
1
- Name:
- GROSSO, Joseph
- Address:
- United States (US)
2
- Name:
- MANEKAS, Demetrios
- Address:
- United States (US)
3
- Name:
- ANDERSON, Jeffrey
- Address:
- United States (US)
Priority
- Priority Number:
- 201562192396 P
- Priority Date:
- 14/07/2015
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 39/00; A61K 39/395; A61P 35/00; C07K 16/28; C12Q 1/70; G01N 33/574; C12Q 1/6886;
Publication
European Patent Bulletin
1
- Issue number:
- 202102
- Publication date:
- 13/01/2021
- Description:
- Grant (B1)
2
- Issue number:
- 202146
- Publication date:
- 17/11/2021
- Description:
- Opposition procedure started
3
- Issue number:
- 202103
- Publication date:
- 20/01/2021
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- 31/07/2025
- Annual Fee Number:
- 10
- Annual Fee Amount:
- 131 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 26/06/2024
- Last Annual Fee Paid Number:
- 9
- Last Annual Fee Paid Amount:
- 115 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 29/01/2021 | Outgoing Correspondence | 1 |
| 27/01/2021 | Power Of Attorney | 1 |
| 12/08/2022 | Request For Change | 1 |
| 02/09/2022 | Outgoing Correspondence | 56 |